1 |
Alagille D, Odievre M, Gautier M, Dommergues JP. Hepatic ductular hypoplasia associated with characteristic facies, vertebral malformations, retarded physical, mental, and sexual development, and cardiac murmur. J Pediatr 1975;86:63-71.
DOI
|
2 |
Kohut TJ, Gilbert MA, Loomes KM. Alagille syndrome: a focused review on clinical features, genetics, and treatment. Semin Liver Dis 2021;41:525-37.
DOI
|
3 |
Kamath BM, Spinner NB, Rosenblum ND. Renal involvement and the role of Notch signalling in Alagille syndrome. Nat Rev Nephrol 2013;9:409-18.
|
4 |
Kamath BM, Podkameni G, Hutchinson AL, Leonard LD, Gerfen J, Krantz ID, et al. Renal anomalies in Alagille syndrome: a disease-defining feature.AmJMedGenetA2012;158A:85-9.
|
5 |
Danks DM, Campbell PE, Jack I, Rogers J, Smith AL. Studies of the aetiology of neonatal hepatitis and biliary atresia. Arch Dis Child 1977;52:360-7.
DOI
|
6 |
Li L, Krantz ID, Deng Y, Genin A, Banta AB, Collins CC, et al. Alagille syndrome is caused by mutations in human Jagged1, which encodes a ligand for Notch1. Nat Genet 1997;16:243-51.
DOI
|
7 |
McDaniell R, Warthen DM, Sanchez-Lara PA, Pai A, Krantz ID, Piccoli DA, et al. NOTCH2 mutations cause Alagille syndrome, a heterogeneous disorder of the notch signaling pathway. Am J Hum Genet 2006;79:169-73.
DOI
|
8 |
Oda T, Elkahloun AG, Pike BL, Okajima K, Krantz ID, Genin A, et al. Mutations in the human Jagged1 gene are responsible for Alagille syndrome. Nat Genet 1997;16:235-42.
DOI
|
9 |
Gilbert MA, Bauer RC, Rajagopalan R, Grochowski CM, Chao G, McEl-drew D, et al. Alagille syndrome mutation update: comprehensive overview of JAG1 and NOTCH2 mutation frequencies and insight intomissense variant classification.HumMutat 2019;40:2197-220.
|
10 |
Bissonnette ML, Lane JC, Chang A. Extreme renal pathology in Alagille syndrome. Kidney Int Rep 2016;2:493-7.
DOI
|
11 |
Crosnier C, Attie-Bitach T, Encha-Razavi F, Audollent S, Soudy F, Hadchouel M, et al. JAGGED1 gene expression during human embryogenesis elucidates the wide phenotypic spectrum of Alagille syndrome. Hepatology 2000;32:574-81.
DOI
|
12 |
McCright B. Notch signaling in kidney development. Curr Opin Nephrol Hypertens 2003;12:5-10.
DOI
|
13 |
Cheng HT, Kim M, Valerius MT, Surendran K, Schuster-Gossler K, Gossler A, et al. Notch2, but not Notch1, is required for proximal fate acquisition in the mammalian nephron. Development 2007;134:801-11.
DOI
|
14 |
Surendran K, Boyle S, Barak H, Kim M, Stomberski C, McCright B, et al. The contribution of Notch1 to nephron segmentation in the developing kidney is revealed in a sensitized Notch2 background and can be augmented by reducing Mint dosage. Dev Biol 2010;337:386-95.
DOI
|
15 |
CKD Work Group. KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int Suppl [Internet]. 2013 [cited 2022 Oct 31];3:1-150. Available from: https://kdigo.org/wp-content/uploads/2017/02/KDIGO_2012_CKD_GL.pdf.
|
16 |
Goodyer P, Gupta IR. Renal dysplasia/hypoplasia. In: Avner E, Harmon WE, Niaudet P, Yoshikawa N, Emma F, Goldstein SL, editors. Pediatric nephrology. 7th ed. Berlin: Springer; 2016. p. 115-34.
|
17 |
Mattoo TK, Mathews R, Gupta IR. Vesicoureteral reflux and renal scarring in children. In: Avner E, Harmon WE, Niaudet P, Yoshikawa N, Emma F, Goldstein SL, editors. Pediatric nephrology. 7th ed. Berlin: Springer; 2017. p. 1715-48.
|
18 |
Schwartz GJ, Haycock GB, Edelmann CM Jr, Spitzer A. A simple estimate of glomerular filtration rate in children derived from body length and plasma creatinine. Pediatrics 1976;58:259-63.
DOI
|
19 |
Liu PM, de Carvalho ST, Fradico PF, Cazumba ML, Campos RG, Simoes E Silva AC. Hepatorenal syndrome in children: a review. Pediatr Nephrol 2021;36:2203-15.
|
20 |
Angeli P, Garcia-Tsao G, Nadim MK, Parikh CR. News in pathophysiology, definition and classification of hepatorenal syndrome: a step beyond the International Club of Ascites (ICA) consensus document. J Hepatol 2019;71:811-22.
DOI
|
21 |
Alagille D, Estrada A, Hadchouel M, Gautier M, Odievre M, Dommergues JP. Syndromic paucity of interlobular bile ducts (Alagille syndrome or arteriohepatic dysplasia): review of 80 cases. J Pediatr 1987;110:195-200.
DOI
|
22 |
Hoffenberg EJ, Narkewicz MR, Sondheimer JM, Smith DJ, Silverman A, Sokol RJ. Outcome of syndromic paucity of interlobular bile ducts (Alagille syndrome) with onset of cholestasis in infancy. J Pediatr 1995;127:220-4.
|
23 |
Russo PA, Ellis D, Hashida Y. Renal histopathology in Alagille's syndrome. Pediatr Pathol 1987;7:557-68.
DOI
|
24 |
Quiros-Tejeira RE, Ament ME, Heyman MB, Martin MG, Rosenthal P, Hall TR, et al. Variable morbidity in alagille syndrome: a review of 43 cases. J Pediatr Gastroenterol Nutr 1999;29:431-7.
DOI
|
25 |
Di Pinto D, Adragna M. Renal manifestations in children with Alagille syndrome. Arch Argent Pediatr 2018;116:149-53.
|
26 |
Habib R, Dommergues JP, Gubler MC, Hadchouel M, Gautier M, Odievre M, et al. Glomerular mesangiolipidosis in Alagille syndrome (arteriohepatic dysplasia). Pediatr Nephrol 1987;1:455-64.
DOI
|
27 |
Nishiura JL, Neves RF, Eloi SR, Cintra SM, Ajzen SA, Heilberg IP. Evaluation of nephrolithiasis in autosomal dominant polycystic kidney disease patients. Clin J Am Soc Nephrol 2009;4:838-44.
DOI
|
28 |
Garcia-Nieto V, Negrete-Pedraza F, Lopez-Garcia M, Luis-Yanes MI. Are simple renal cysts in childhood associated with kidney stones? Nephrourol Mon 2012;4:596-8.
DOI
|
29 |
Torres VE, Wilson DM, Hattery RR, Segura JW. Renal stone disease in autosomal dominant polycystic kidney disease. Am J Kidney Dis 1993;22:513-9.
DOI
|